Viewing Study NCT04592666

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:31 PM
Ignite Modification Date: 2026-02-02 @ 9:48 AM
Study NCT ID: NCT04592666
Status: UNKNOWN
Last Update Posted: 2020-10-19
First Post: 2020-09-22
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Almonertinib/Pemetrexed/Carboplatin in EGFR T790M+ Advanced Lung Cancer
Sponsor: Fudan University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lung Cancer, Non-small Cell View
None EGFR T790M View
None EGFR Gene Mutation View
Keywords:

Keywords

Keyword Brief Keyword Text View
None lung cancer View
None EGFR View
None Combination therapy View
None Almonertinib View